title: Do the effects of long-term lomerizine administration differ with age?
authors.affiliation: Department of Neurology, Shizuoka Red Cross Hospital, Shizuoka, Japan. nboimai@ac.mbn.or.jp
authors.forename: Noboru
authors.initials: N
authors.lastname: Imai
authors.forename: Takashi
authors.initials: T
authors.lastname: Konishi
authors.forename: Masahiro
authors.initials: M
authors.lastname: Serizawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Okabe
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000517:prevention & control; D010879:Piperazines / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D002121:Calcium Channel Blockers; D010879:Piperazines; C052424:lomerizine